288 related articles for article (PubMed ID: 26524334)
21. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
22. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR; Dittmer DP
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Kedes DH; Ganem D
J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779
[TBL] [Abstract][Full Text] [Related]
24. Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.
Chatterjee D; Chandran B; Berger EA
MAbs; 2012; 4(2):233-42. PubMed ID: 22377676
[TBL] [Abstract][Full Text] [Related]
25. Hsp70 Isoforms Are Essential for the Formation of Kaposi's Sarcoma-Associated Herpesvirus Replication and Transcription Compartments.
Baquero-Pérez B; Whitehouse A
PLoS Pathog; 2015 Nov; 11(11):e1005274. PubMed ID: 26587836
[TBL] [Abstract][Full Text] [Related]
26. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency.
Ye F; Zhou F; Bedolla RG; Jones T; Lei X; Kang T; Guadalupe M; Gao SJ
PLoS Pathog; 2011 May; 7(5):e1002054. PubMed ID: 21625536
[TBL] [Abstract][Full Text] [Related]
28. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK.
Chen J; Jiang L; Lan K; Chen X
Viruses; 2015 May; 7(5):2268-87. PubMed ID: 25951487
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
Zhang YJ; Patel D; Nan Y; Fan S
Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
[TBL] [Abstract][Full Text] [Related]
31. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Medveczky MM; Horvath E; Lund T; Medveczky PG
AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
[TBL] [Abstract][Full Text] [Related]
32. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.
Schulz TF
J Antimicrob Chemother; 2000 Apr; 45 Suppl T3():15-27. PubMed ID: 10855768
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
35. NEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV target.
Hughes DJ; Wood JJ; Jackson BR; Baquero-Pérez B; Whitehouse A
PLoS Pathog; 2015 Mar; 11(3):e1004771. PubMed ID: 25794275
[TBL] [Abstract][Full Text] [Related]
36. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.
Vieira J; O'Hearn P; Kimball L; Chandran B; Corey L
J Virol; 2001 Feb; 75(3):1378-86. PubMed ID: 11152511
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
38. Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.
Kong X; Li D; Mansouri A; Kang G; Sayood K; West J; Wood C
J Virol; 2021 Jun; 95(13):e0000321. PubMed ID: 33853962
[TBL] [Abstract][Full Text] [Related]
39. Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.
Cai Q; Verma SC; Lu J; Robertson ES
Adv Virus Res; 2010; 78():87-142. PubMed ID: 21040832
[TBL] [Abstract][Full Text] [Related]
40. Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation.
Deng JH; Zhang YJ; Wang XP; Gao SJ
J Virol; 2004 Oct; 78(20):11108-20. PubMed ID: 15452231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
